Better Therapeutics Inc
Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease… Read more
Market Cap & Net Worth: Better Therapeutics Inc (BTTX)
Better Therapeutics Inc (OTCMKTS:BTTX) has a market capitalization of $5.45K ($5.45K) as of March 18, 2026. Listed on the OTCMKTS stock exchange, this USA-based company holds position #47022 globally and #14586 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Better Therapeutics Inc's stock price $0.00 by its total outstanding shares 54515600 (54.52 Million).
Better Therapeutics Inc Market Cap History: 2021 to 2024
Better Therapeutics Inc's market capitalization history from 2021 to 2024. Data shows change from $253.50 Million to $5.45K (-95.54% CAGR).
Better Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Better Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BTTX by Market Capitalization
Companies near Better Therapeutics Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Better Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Better Therapeutics Inc Historical Marketcap From 2021 to 2024
Between 2021 and today, Better Therapeutics Inc's market cap moved from $253.50 Million to $ 5.45K, with a yearly change of -95.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $5.45K | -99.95% |
| 2023 | $10.63 Million | -82.35% |
| 2022 | $60.24 Million | -76.24% |
| 2021 | $253.50 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 26th, 2025 the market cap of Better Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.45K USD |
| MoneyControl | $5.45K USD |
| MarketWatch | $5.45K USD |
| marketcap.company | $5.45K USD |
| Reuters | $5.45K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.